State of the Art and Science
Apr 2003

Wilson's Disease: Diagnosis and Treatment

Audiey Kao, MD, PhD
Virtual Mentor. 2003;5(4):108-109. doi: 10.1001/virtualmentor.2003.5.4.cprl1-0304.

 

Wilson's disease is an autosomal recessive disorder that results in copper accumulation and toxicity and occurs in about 1 out of every 40,000 people [1]. As a result of copper deposition in various organs, patients, typically between the ages of 10 and 40 years old, can present with liver, neurological, or psychiatric symptoms. In fact, one fourth to one third of patients initially present with psychiatric and behavioral symptoms [2,3]. Kinnier Wilson, in his initial case reports, described the behavioral aspects of the disease, which he called "psychical," and noted their presence in 8 of his 12 patients [4].

Diagnosis and Physical Findings

The Kayser-Fleischer ring, a brownish-green discoloration from accumulation of copper granules deposited in the sclera at the periphery of the cornea, is virtually pathognomonic of Wilson's disease. Wilson's disease often presents in the following ways:

  • Psychiatric – the previously psychiatrically "normal" young person can present depression, manic behavior, paranoia, and delusions, but the commonest disturbances are "bizarre behavioral patterns that defy classification."
  • Neurologic – the patient may present with slurred or slowed speech, tremors, dystonia, and dysphagia. Motor strength is not affected, nor are there sensory defects.
  • Hepatic – the patient may present with hepatitis, chronic cirrhosis, or liver failure.

Positive screening test results include urine copper (over 100 micrograms/24 hour) and serum ceruloplasmin (below 5 milligrams/dl). For any patient in whom the diagnosis is not definitive, the gold standard is liver biopsy (over 2000 micrograms/g dry weight of tissue).

Initial Management and Maintenance Therapy

Wilson's Disease is an unusual genetic disease in that it is quite effectively treated (Table 1). Therefore, even though the disorder is rare, it is important to consider it in differential diagnosis, because failure to treat can lead to permanent damage including psychiatric and behavioral problems. The staple of maintenance treatment is zinc, which has much fewer side effects than previous medications such as pencillamine. Zinc's use as treatment for Wilson's Disease was discovered when it caused copper deficiency while being studied as an antisickling agent in patients with sickle cell anemia [6]. Zinc acts by inducing intestinal metallothionein, and thus, prevents absorption of copper into the circulation.

Table 1: Anticopper Therapy for Different Categories of
Wilson's Disease Patients

Category of patient

Treatment of choice

Initial presentation
Psychiatric
Neurological
Hepatic

Tetrathiomolybdate
Tetrathiomolybdate
Tientine and zinc

Maintenance therapy
Maintenance and initial therapy
Presymptomatic
Pregnant
Pediatric

Zinc
Zinc
Zinc
Zinc

 

References

  1. Schilsky ML. Wilson disease: genetic basis of copper toxicity and natural history. Semin Liver Dis. 1996;16(1):83-95.
  2. Jackson GH, Meyer A, Lippmann S. Wilson's disease. Psychiatric manifestations may be the clinical presentation. Postgrad Med. 1994;95(8):135-138.
  3. Akil M, Brewer GJ. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol. 1995;65:171-178.

  4. Wilson SAK. Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver. Brain. 1912;34:295-507.

  5. Brewer GJ. Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med. 2000;223(1):39-46.
  6. Prasad AS, Brewer GJ, Schoomaker EB, Rabbini P. Hypocupremia induced by zinc therapy in adults. JAMA. 1978;240(20):2166-2168.

Citation

Virtual Mentor. 2003;5(4):108-109.

DOI

10.1001/virtualmentor.2003.5.4.cprl1-0304.

The viewpoints expressed in this article are those of the author(s) and do not necessarily reflect the views and policies of the AMA.